新疆疏附县人民医院心脑血管疾病发病趋势及高血压危险因素分析

doi:10.3969/j.issn.1000-8535.2018.02.009

广州医药 ›› 2018, Vol. 49 ›› Issue (2): 33-37.DOI: 10.3969/j.issn.1000-8535.2018.02.009

新疆疏附县人民医院心脑血管疾病发病趋势及高血压危险因素分析

黎艳芳¹, 关天旺¹, 图提古丽·麦麦提², 阿不都热西提·则亚维丁², 刘城^1,2

1 广州医科大学附属市一人民医院心血管内科(广州 510180)
2 新疆维吾尔自治区喀什地区疏附县人民医院(喀什 844100)

收稿日期:2017-10-11 出版日期:2018-03-20 发布日期:2021-12-01
通讯作者: 刘城,E-mail:adrian_liu@msn.cn
基金资助:
新疆维吾尔自治区自然科学基金资助项目(201318101-12);广东省科技计划项目(2014A020212372)

Incidence trend of cardio-cerebrovascular disease and risk factors about hypertension in Shufu People's hospital of Xinjiang

LI Yanfang¹, GUAN Tianwang¹, TUTIGULI Maimaiti², ABUDUREXITI Zeyaweiding², LIU Cheng^1,2

1 Department of Cardiology, Guangzhou First People's Hospital,Guangzhou 510180,China
2 Shufu People's Hospital, Kashgar Prefecture, Xinjiang Uygur Autonomous Region, Kashgar 844100,China

Received:2017-10-11 Online:2018-03-20 Published:2021-12-01

摘要/Abstract

摘要： 目的了解新疆疏附县人民医院心脑血管疾病发病趋势和分析高血压发病相关危险因素,为高血压及其相关的心脑血管疾病的综合防治提供依据。方法回顾性分析2007—2011年疏附县人民医院住院患者资料,按年份统计慢性非传染性疾病(以下简称慢性病)住院人数情况,并采用Logistic回归分析法分析维吾尔族人群高血压发病的相关危险因素。结果新疆疏附县人民医院心脑血管疾病住院人数逐年增长,5年增长了约2.7倍,其中因高血压住院人数增长了3.5倍。BMI、血钠水平升高、血脂异常、年龄是维吾尔族人群高血压的危险因素。结论新疆疏附县人民医院住院患者中以高血压为主的心脑血管疾病逐年增长。当地高血压及其相关的心脑血管疾病的防治采取生活方式干预基础上给予降压、降脂治疗的综合策略是优选。

关键词: 高血压, 心脑血管疾病, 新疆, 维吾尔族

Abstract: Objective To investigate the incidence trend of cardio-cerebrovascular disease and the related risk factors about hypertension in Shufu people's hospital of Xinjiang. Moreover, to provide evidence of making prevention and controlling strategies for hypertension and the related cardio-cerebrovascular diseases.Methods A retrospective review was did on case data of the inpatients in Shufu people's hospital during 2007-2011.We counted the number of inpatients of chronic non-communicable diseases(NCDs)by year and collected the information of hypertensive inpatients and non-hypertensive inpatients to analyze the risk factors of hypertension in Uygurs using Logistic regression.Results The number of inpatients with cardio-cerebrovascular disease in Shufu people's hospital was increased by 2.7 times in 5 years, while the number of hypertensive inpatients was increased by 3.5 times. BMI, elevated blood sodium, and dyslipidemia, age are risk factors for hypertension in Uygur population.Conclusion The inpatients with cardio-cerebrovascular disease especially those with hypertension in Shufu people's hospital were increasing in recent 5 years. The strategy of lifestyle intervention combined with antihypertensive as well as lipid-lowering therapy is better to the prevention and treatment of hypertension and the related cardio-cerebrovascular diseases.

Key words: Hypertension, Cardio-cerebrovascular diseases, Xinjiang, The Uygurs

黎艳芳, 关天旺, 图提古丽·麦麦提, 阿不都热西提·则亚维丁, 刘城. 新疆疏附县人民医院心脑血管疾病发病趋势及高血压危险因素分析[J]. 广州医药, 2018, 49(2): 33-37.

LI Yanfang, GUAN Tianwang, TUTIGULI Maimaiti, ABUDUREXITI Zeyaweiding, LIU Cheng. Incidence trend of cardio-cerebrovascular disease and risk factors about hypertension in Shufu People's hospital of Xinjiang[J]. Guangzhou Medical Journal, 2018, 49(2): 33-37.

参考文献

[1] 赖艳娴, 邓聪, 郭宝云, 等.维族原发性高血压人群ACE多态性及水平相关性分析[J].广州医药,2015,43(4):20-22.
[2] 王红梅, 李南方, 姚晓光, 等. 新疆阜康牧区哈萨克族人群高血压的群体流行病学研究[J]. 中华高血压杂志, 2010, 18(10): 960-964.
[3] 赵蕾,王坤, 郭艳英, 等. 新疆博尔塔拉蒙古自治州蒙、哈、维、汉4民族30岁以上高血压及部分有关危险因素调查[J]. 高血压杂志, 2006,14 (3): 214-218.
[4] 郭淑霞, 张景玉, 张翼华, 等. 新疆哈萨克族与汉族高血压流行病学特点比较与分析[J]. 石河子大学学报(自然科学版), 2008, 26(5): 538-540.
[5] 刘力生. 中国高血压防治指南2010[J]. 中华高血压杂志, 2011,19 (8): 701-743.
[6] EZZATI M, LOPEZ A D, RODGERS A, et al. Selected major risk factors and global and regional burden of disease[J]. The Lancet, 2002, 360(9343): 1347-1360.
[7] DICKINSON H O, MASON J M, NICOLSON D J, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials[J]. J Hypertens, 2006, 24(2): 215-233.
[8] 赵声超, 赵鹏, 郭亚伟,等.深圳市社区40岁以上人群脑卒中危险因素现况[J]. 现代医院, 2017,17(6):844-848.
[9] LAW M R, MORRIS J K, WALD N J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies[J]. Bmj, 2009, 19(338): b1665.
[10] SEVER P S, DAHL F B, POULTER, et al. Prevention of coronary and stroke events with atorvastatin In hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre Randomized controlled trial[J]. The Lancet,2003,361(9364): 1149-1158.

[1]	何同林, 何兰, 刘俊, 刘俊华, 阮宪东, 朱艳红. 高通量透析模式对改善维持性血液透析患者β2微球蛋白清除率及高血压的影响[J]. 广州医药, 2021, 52(5): 35-39.
[2]	刘剑波. 神经内镜和常规开颅手术治疗高血压脑出血的优劣分析[J]. 广州医药, 2018, 49(6): 37-39.
[3]	银孟卓, 卢建文. 血浆chemerin水平与原发性高血压合并永久性心房纤颤的相关性研究[J]. 广州医药, 2018, 49(4): 13-16.
[4]	陈露丝, 岳晓军, 李韶南, 陈平安, 冯开薇, 吕何锦, 刘震. 社区综合防治合作模式对基层高血压病患者的药物经济学评价[J]. 广州医药, 2018, 49(4): 24-29.
[5]	肖媚, 李文礼, 罗伟汀. 丹参酮ⅡA磺酸钠不同时点给药在高血压性脑出血治疗中的疗效及对神经保护作用[J]. 广州医药, 2018, 49(3): 91-93.
[6]	马程远, 关键, 张中宏, 梁文晋, 任侠, 王耀林. HHIP基因rs13118928、rs13141461与新疆蒙古族慢性阻塞性肺疾病易感性的相关性研究[J]. 广州医药, 2018, 49(2): 1-5.
[7]	赵位昆, 徐彤彤, 胡迪聃, 张向宇, 吕祥威. 瘦素对高血压肾损害相关机制的研究进展[J]. 广州医药, 2018, 49(1): 110-113.
[8]	王育胜, 洪映标, 黄正华, 彭晖. 小骨窗显微手术不同手术时机对高血压脑出血患者疗效及神经功能的影响[J]. 广州医药, 2017, 48(3): 46-48.
[9]	张向宇, 徐彤彤, 胡迪聃, 王文艳. 高血压合并代谢综合征患者血清瘦素与靶器官损伤的研究进展[J]. 广州医药, 2017, 48(2): 105-108.
[10]	蔡胜业. 硝苯地平与厄贝沙坦联合治疗青年原发性高血压的临床效果分析[J]. 广州医药, 2016, 47(1): 97-98.
[11]	曾秀梅, 刘丰. 社区老年高血压病人直立性低血压的药物影响研究[J]. 广州医药, 2015, 46(5): 84-85.
[12]	罗文辉, 陈建平, 李金连, 李国文, 李莉珊. D-二聚体、超敏C反应蛋白在年轻原发性高血压病患者血清中的表达及相关性研究[J]. 广州医药, 2015, 46(4): 32-33.
[13]	赖艳娴, 郭宝云, 邓聪, 阿不都热西提·则亚维丁, 刘城, 陈文忠, 刘凯. 新疆维吾尔族、汉族原发性高血压患者ACE多态性分析[J]. 广州医药, 2015, 46(3): 12-15.
[14]	何雪梅, 何碧, 李小燕. 压力管理对改善中年高血压患者生活质量的影响[J]. 广州医药, 2015, 46(3): 56-57.
[15]	林穗智. 硝苯地平缓释片治疗高血压合并糖尿病的疗效观察[J]. 广州医药, 2015, 46(2): 93-94.

新疆疏附县人民医院心脑血管疾病发病趋势及高血压危险因素分析

Incidence trend of cardio-cerebrovascular disease and risk factors about hypertension in Shufu People's hospital of Xinjiang

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价